Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer


MicroRNAs (miRs) are interesting new diagnostic targets that may provide important insights into the molecular pathogenesis of breast cancer. Here we evaluated, for the first time, the feasibility and clinical utility of circulating miRs as biomarkers for the detection and staging of breast cancer. The relative concentrations of breast cancer-associated… (More)
DOI: 10.1186/bcr2766

3 Figures and Tables


  • Presentations referencing similar topics